NYSE : LH
Labcorp Holdings Inc. — Key statistics
Healthcare · Diagnostics & Research · United States
Last price 361.39 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 29.34B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 29.34B |
| Enterprise Value | 35.93B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Nov 24, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 81.20M |
| Shares Outstanding | 81.20M |
| Shares Change (YoY) | -1.96% |
| Shares Change (QoQ) | -0.49% |
| Owned by Insiders (%) | 0.39% |
| Owned by Institutions (%) | 102.20% |
| Float | 80.82M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 29.67 |
| Forward PE | 18.77 |
| PS Ratio | 2.01 |
| Forward PS | 1.90 |
| PB Ratio | 3.32 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 22.80 |
| P/OCF Ratio | 16.17 |
| PEG Ratio | 2.01 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 35.79 |
| EV / Sales | 2.46 |
| EV / EBITDA | 15.32 |
| EV / EBIT | 22.03 |
| EV / FCF | 27.92 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.41 |
| Quick Ratio | 1.00 |
| Debt / Equity | 0.77 |
| Debt / EBITDA | 2.59 |
| Debt / FCF | 5.32 |
| Interest Coverage | 7.08 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 11.44% |
| Return on Assets (ROA) | 5.48% |
| Return on Invested Capital (ROIC) | 8.71% |
| Return on Capital Employed (ROCE) | 10.13% |
| Weighted Average Cost of Capital (WACC) | 7.74% |
| Revenue Per Employee | $205,556 |
| Profits Per Employee | $14,141 |
| Employee Count | 71,000 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 19.56 |
Taxes
| Measure | Value |
|---|
| Income Tax | 219.60M |
| Effective Tax Rate | 17.93% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.85 |
| 52-Week Price Change | +45.64% |
| 50-Day Moving Average | 323.22 |
| 200-Day Moving Average | 287.55 |
| Relative Strength Index (RSI) | 74.54 |
| Average Volume (20 Days) | 734,495 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.56M |
| Short Previous Month | 2.45M |
| Short % of Shares Out | 3.15% |
| Short % of Float | 3.16% |
| Short Ratio (days to cover) | 3.39 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 14.59B |
| Gross Profit | 4.23B |
| Operating Income | 1.63B |
| Pretax Income | 1.22B |
| Net Income | 1.00B |
| EBITDA | 2.34B |
| EBIT | 1.63B |
| Earnings Per Share (EPS) | $12.18 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 261.80M |
| Total Debt | 6.85B |
| Net Cash | -6.59B |
| Net Cash Per Share | -$81.11 |
| Equity (Book Value) | 8.86B |
| Book Value Per Share | 108.96 |
| Working Capital | 1.15B |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 1.82B |
| Capital Expenditures | -528.10M |
| Depreciation & Amortization | 713.80M |
| Net Borrowing | 250.00M |
| Free Cash Flow | 1.29B |
| FCF Per Share | $15.85 |
Margins
| Measure | Value |
|---|
| Gross Margin | 28.96% |
| Operating Margin | 11.18% |
| Pretax Margin | 8.39% |
| Profit Margin | 6.88% |
| EBITDA Margin | 16.07% |
| EBIT Margin | 11.18% |
| FCF Margin | 8.82% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $2.88 |
| Dividend Yield | 0.80% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 23.65% |
| FCF Payout Ratio | 18.17% |
| Buyback Yield | 1.96% |
| Shareholder Yield | 2.76% |
| Earnings Yield | 3.37% |
| FCF Yield | 4.39% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $382.25 |
| Price Target Difference | 5.77% |
| Analyst Consensus | Buy |
| Analyst Count | 17 |
| Revenue Growth Forecast (3Y) | 5.41% |
| EPS Growth Forecast (3Y) | 8.84% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 13, 2002 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.15 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |